The use of platelet-rich fibrin in the treatment of patients with inflammatory diseases of the maxillofacial area (a literature review)
https://doi.org/10.52581/1814-1471/92/05
Abstract
The purpose of this work was to study the use of platelet-rich fibrin in the treatment of patients with inflammatory diseases of the maxillofacial area.
Due to the lack of a tendency to reduce morbidity and mortality in this group of patients, the problem of their treatment remains one of the most pressing to date. Treatment of wounds resulting from surgical debridement of a purulent-septic focus in the purification and proliferation phase involves the use of various means and techniques aimed at stimulating regeneration. The particular interest is the use of platelet concentrates (autologous platelet rich plasma and platelet-rich fibrin obtained from it). According to most literary sources, platelet-rich fibrin in dentistry and maxillofacial surgery is used primarily in dental implantology. Significantly fewer publications are devoted to the use of platelet-rich fibrin in the treatment of patients with inflammatory diseases of the lower jaw. The use of platelet-rich fibrin in the treatment of patients with inflammatory diseases of the soft tissues of the maxillofacial area and neck has so far remained outside the field of view of researchers and requires further study.
About the Authors
M. M. Khodorkovskiy
Voronezh State Medical University named after N.N. Burdenko
Russian Federation
Russian Federation
Mikhail M. Khodorkovskiy, postgraduate student, the Department of Surgical Dentistry
10, Studencheskaya st., Voronezh, 394036
I. V. Stepanov
Voronezh State Medical University named after N.N. Burdenko
Russian Federation
Russian Federation
Iliya V. Stepanov, Dr. Med. sci., Professor, the Department of Surgical Dentistry
10, Studencheskaya st., Voronezh, 394036
M. A. Khodorkovskiy
Voronezh State Medical University named after N.N. Burdenko
Russian Federation
Russian Federation
Mark A. Khodorkovskiy, Dr. Med. sci., Professor, the Department of Specialized Surgical Disciplines
10, Studencheskaya st., Voronezh, 394036
References
1. Sipkin A.M., Davydov I.A., Akhtyamov D.V., Blagikh O.E. Odontogenic purulent-inflammatory diseases of maxillofacial area: modern view on treatment and rehabilitation. Klinicheskaya stomatologiya – Clinical Dentistry (Russia). 2018;2(86):66-69. (In Russ.). doi: 10.37988/1811-153X_2018_2_66
2. Afanasiev V.V., Yanushevich O.O., Urgunaliev B.K. Abscesses and phlegmons of the maxillofacial area and neck. Atlas: Study Guide. Moscow, GEOTAR-Media Publ., 2019:120 p. (In Russ.).
3. Orazvaliev A.I., Dubov D.V., Vagner O.N. The Statistical analysis of the frequency and structure of purulentinflammatory diseases of the maxillofacial region on the materials of the Department of Maxillofacial Surgery № 2 of Inozemtsev Municipal Clinical Hospital. Russian Journal of Stomatology – Rossiiskaya stomatologiya. 2020;13(2):12-15. (In Russ.). doi: 10.17116/rosstomat20201302112
4. Samsonov V.V., Gizinger O.A., Zhmud M.V., Lovtsevich S.M. Purulent-inflammatory diseases of the maxillofacial area: review aspects of the clinic, immunology, microbiology and diagnostics in treatment planning. Terapevt – General Physician. 2024;12. (In Russ.). doi: 10.33920/MED-12-2412-05
5. Markarov A.E., Eremin D.A., Orazvaliev A.I., Martirosov A.V., Krasnov N.M., Shen P.A., Nikol'skaya I.A., Bugayan S.A., Kamskov M.S., Reut A.A. The statistical analysis of purulent-inflammatory diseases of the maxillo-facial region. Meditsinskiy alfavit – Medical Alphabet. 2022; 7: 40-46. (In Russ.). doi: 10.33667/2078-5631-2022-7-40-46
6. Kulakov A.A. (Ed.) Maxillofacial Surgery. National Guide. Moscow, GEOTAR-Media Publ., 2023:696 p. (in Russ.).
7. Kozlov A.V., Gusyakova O.A., Lyamin A.V., Ketsko Yu.L., Khaliulin A.V., Ereshchenko A.A. Polyresistent microflora in the structure of microorganisms divided from blood of patients of the general hospital. Klinicheskaya Laboratornaya Diagnostika – Russian Clinical Laboratory Diagnostics. 2018;63(9):574-578. (In Russ.). doi: 10.18821/0869-2084-2018-63-9-574-578.
8. Beloborodov V.B., Goloschapov O.V., Gusarov V.G., Dekhnich A.V. Zamyatin M.N., Zubareva N.A, Zyryanov S.K., Kamyshova D.A., Klimko N.N, Kozlov R.S., Kulabukhov V.V., Petrushin M.A., Polushin Yu.S., Popov D.A., Rudnov V.A., Sidorenko S.V, Sokolov D.V., Shlyk I.V., Edelshtein M.V., Yakovlev S.V. Guidelines of the Association of Anesthesiologists-Intensivists, the Interregional Non-Governmental Organization Alliance of Clinical Chemotherapists and Microbiologists, the Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy (IACMAC), and NGO Russian Sepsis Forum “Diagnostics and antimicrobial therapy of the infections caused by multiresistant microorganisms” (update 2022). Vestnik anesteziologii i reanimatologii – Messenger of Anesthesiology and Resuscitation, 2022;19(2):84-114. (In Russ.). doi: 10.21292/2078-5658-2022-19-2-84-114
9. Kingsley C.S. Blood coagulation; evidence of an antagonist to factor VI in platelet-rich human plasma. Nature. 1954;173(4407):723-724. doi: 10.1038/173723a0
10. Guo S., Dipietro L.A. Factors affecting wound healing. J Dent Res. 2010;89(3):219-229. doi: 10.1177/0022034509359125
11. Alekseeva N.T., Klochkova S.V., Nikityuk D.B., Glukhov A.A. Skin regeneration: current methods of influence. Voronezh, Nauchnaya kniga Publ., 2015:300 p. (In Russ.).
12. Gosain A., DiPietro L.A. Aging and wound healing. World J Surg. 2004;28(3):321-326. doi: 10.1007/s00268-003-7397-6
13. Eming S.A., Brachvogel B., Odorisio T., Koch M. Regulation of angiogenesis: wound healing as a model. Prog Histochem Cytochem. 2007; 42(3): 115-170. doi: 10.1016/j.proghi.2007.06.001
14. Cromack D.T., Porras-Reyes B., Mustoe T.A. Current concepts in wound healing: growth factor and macrophage interaction. J Trauma. 1990;30(Suppl 12):129-133. doi: 10.1097/00005373-199012001-00026
15. Pierce G.F., Mustoe T.A., Altrock B.W., Deuel T.F., Thomason A. Role of platelet-derived growth factor in wound healing. J Cell Biochem. 1991;45(4):319-326. doi: 10.1002/jcb.240450403
16. Nurden A.T. Platelets, inflammation and tissue regeneration. Thromb Haemost. 2011;105(Suppl 12):13-33. doi: 10.1160/THS10-11-0720
17. Currie G.A. Platelet-derived growth-factor requirements for in vitro proliferation of normal and malignant mesenchymal cells. Br J Cancer. 1981;3:335-343. doi: 10.1038/bjc.1981.53
18. Gehring S., Hoerauf H., Laqua H., Kirchner H., Klüter H. Preparation of autologous platelets for the ophthalmologic treatment of macular holes. Transfusion. 1999;39(2):144-148. doi: 10.1046/j.1537-2995.1999.39299154727.x
19. Marx R.E., Carlson E.R., Eichstaedt R.M., Schimmele S.R., Strauss J.E., Georgeff K.R. Platelet-rich plasma: Growth factor enhancement for bone grafts. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 1998;85(6):638-646. doi: 10.1016/s1079-2104(98)90029-4
20. Marx E.R., Lynch S.E., Genco R.J., Marx R.E. Platelet-rich plasma: A source of multiple autologous growth factors for bone grafts. Tissue engineering, applications in maxillofacial surgery and periodontics. Illinois, Quintessence Publishing Co Inc, 1999:71-82.
21. Garg A.K. The use of platelet-rich plasma to enhance the success of bone grafts around dental implants. Dent Implantol Update. 2000;11(3):17-21.
22. Boldyreva O.V., Vakhrushev S.G., Toropova L.A. The use of platelet-rich plasma in medical practice. Sovremennye problemy nauki i obrazovaniya. 2016; 5 (in Russ.). URL: https://science-education.ru/ru/article/view?id=25196 (accessed 31 January 2025)
23. Garifov A.F., Garifov I.F., Dyumeev R.M. Regenerative medicine methods based on autologous plasma. Innovative technologies in dentistry: Proceedings of the XXIV International Anniversary Symposium, Omsk, November 24–25, 2017. Omsk, 2017. P. 94–96. (In Russ.).
24. Matchin A.A., Stadnikov A.A., Nosov E.V., Blinova E.V., Ryskulov M.F., Klevtsov G.V. Experimental and Histological Validation of Nanostructured Products Use in Maxillofacial Surgery. Zhurnal anatomii i gistopatologii – Journal of Anatomy and Histopathology. 2024; 13(3):41-48 (in Russ.). doi: 10.18499/2225-7357-2024-13-3-41-48
25. Choukroun J., Adda F., Schoeffler C., Vervelle A. Une opportunite en paro-implantologie: Le PRF. Implantodontie. 2000;42:55-62.
26. Dohan D.M., Choukroun J., Diss A., Dohan S.L., Dohan A.J., Mouhyi J., Gogly B. Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part I: technological concepts and evolution. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 2006;101(3):e37-44. doi: 10.1016/j.tripleo.2005.07.008
27. Lundquist R., Dziegiel M.H., Agren M.S. Bioactivity and stability of endogenous fibrogenic factors in plateletrich fibrin Wound Repair Regen. 2008;16(3):356-363. doi: 10.1111/j.1524-475X.2007.00344.x
28. Lundquist R., Holmstrøm K., Clausen C., Jørgensen B., Karlsmark T. Characteristics of an autologous leukocyte and platelet-rich fibrin patch intended for the treatment of recalcitrant wounds. Wound Repair Regen. 2013;21(1):66-76. doi: 10.1111/j.1524-475X.2012.00870.x
29. Bayer A., Lammel J., Rademacher F., Groß J., Siggelkow M., Lippross S., Klüter T., Varoga D., Tohidnezhad M., Pufe T., Cremer J., Gläser R., Harder J. Platelet-released growth factors induce the antimicrobial peptide human beta-defensin-2 in primary keratinocytes. Exp Dermatol. 2016;25(6):460-465. doi: 10.1111/exd.12966
30. Ghanaati S., Booms P., Orlowska A., Kubesch A., Lorenz J., Rutkowski J., Landes C., Sader R., Kirkpatrick C., Choukroun J. Advanced platelet-rich fibrin: a new concept for cell-based tissue engineering by means of inflammatory cells. J Oral Implantol. 2014;40(6):679-689. doi: 10.1563/aaid-joi-D-14-00138
31. De Pascale M.R., Sommese L., Casamassimi A., Napoli C. Platelet derivatives in regenerative medicine: an update. Transfus Med Rev. 2015;29(1):52-61. doi: 10.1016/j.tmrv.2014.11.001
32. Miron R.J., Fujioka-Kobayashi M., Bishara M., Zhang Y., Hernandez M., Choukroun J. Platelet-Rich Fibrin and Soft Tissue Wound Healing: A Systematic Review. Tissue Eng. Part B Rev. 2017;23(1):83-99. doi: 10.1089/ten.TEB.2016.0233
33. Chen L., Ding Y., Cheng G., Meng S. Use of Platelet-Rich Fibrin in the Treatment of Periodontal Intrabony Defects: A Systematic Review and Meta-Analysis. Biomed Res Int. 2024;20(2024):9838732. doi: 10.1155/2024/9838732
34. Ghanaati S., Herrera-Vizcaino C., Al-Maawi S., Lorenz J., Miron R.J., Nelson K., Schwarz F., Choukroun J., Sader R. Fifteen Years of Platelet Rich Fibrin in Dentistry and Oromaxillofacial Surgery: How High is the Level of Scientific Evidence? J Oral Implantol. 2018;44(6):471-492. doi: 10.1563/aaid-joi-D-17-00179
35. Miron R.J., Moraschini V., Fujioka-Kobayashi M., Zhang Y., Kawase T., Cosgarea R., Jepsen S., Bishara M., Canullo L., Shirakata Y., Gruber R., Ferenc D., Calasans-Maia M.., Wang H.L., Sculean A. Use of platelet-rich fibrin for the treatment of periodontal intrabony defects: a systematic review and meta-analysis. Clin Oral Investig. 2021;25(5):2461-78. doi: 10.1007/s00784-021-03825-8
36. Salloum A. Current applications of platelet-rich fibrin in dental surgery and reconstructive surgery of the alveolar ridges. Verkhnevolzhskiy meditsinskiy zhurnal – Upper Volga Medical Journal, 2024;23(3):8-11.
37. Pakhlevanyan S.G., Shevchenko L.V., Shevchenko A.Yu., Pakhlevanyan V.G., Pakhlevanyan G.G. Revisiting the Use of Platelet-Rich Fibrin Clots. Aktual'nye problemy meditsiny – Challenges in Modern Medicine. 2022; 45(4): 388-399 (in Russ.). doi: 10.52575/2687-0940-2022-45-4-388-399
38. Biao Cheng, Xiaobing Fu. Platelet-Rich Plasma in Tissue Repair and Regeneration. Springer. 2023:182 p. doi: 10.1007/978-981-99-3193-4
39. Makarova A.M. The use of platelet-rich fibrin in the treatment of odontogenic diseases of the maxillofacial area // Proceedings of the XVI International Burdenko Scientific Conference. Voronezh, April 23–25, 2020. Voronezh, 2020. P. 278–280. (In Russ.).
40. Andreev A.A., Stepanov I.V., Khryachkov V.I., Khodorkovskiy M.M., Kikov R.N. Application of platelet-enriched fibrin in patients with inflammatory diseases of maxillofacial region. Prikladnye informatsionnye aspekty meditsiny – Applied Information Aspects of Medicine, 2020; 23(3): 14-19. (in Russ.). doi: 10.18499/2070-9277-2020-23-3-14-19
41. Andreev A.A., Stepanov I.V., Khryachkov V.I., Podoprigora A.V., Khodorkovskiy M.M., Gulyaev O.A. Use of platelet-rich fibrin in the treatment of osteonecrosis of the lower jaw. Smolenskiy meditsinskiy al'manakh. 2020; 3: 20-24 (in Russ.).
Review
For citations:
Khodorkovskiy M.M., Stepanov I.V., Khodorkovskiy M.A. The use of platelet-rich fibrin in the treatment of patients with inflammatory diseases of the maxillofacial area (a literature review). Issues of Reconstructive and Plastic Surgery. 2025;28(1):44-50. (In Russ.) https://doi.org/10.52581/1814-1471/92/05
Views:
47
Email this article 